Recurrent Pericardial Effusions Following a Pacemaker Implant: A Case Report
Abstract
Background: Post-cardiac injury syndrome (PCIS) is described as the onset of pericarditis with or without pericardial effusion after recent cardiac injury.Pacemaker placements can cause PCIS, but its incidence is often overlooked.This case report describes a patient who experienced recurrent pericardial effusion after pacemaker implant due to PCIS.While cases of PCIS after pacemaker implantation have been reported, this case is unique in its kind due to the presentation of recurrent pericardial effusions.Case Description: A 91-year-old male, with a history of bradycardia that was recently treated with a pacemaker, presented to the emergency department in September 2023 with a chief complaint of dyspnea.His medical history was significant for type 2 diabetes mellitus, chronic obstructive pulmonary disease, and chronic kidney disease.Two months prior, the patient received a dual-chambered Biotronik pectoral pacemaker.One month prior, the patient suffered a pericardial effusion with pericarditis and pericardial tamponade.Vitals demonstrated tachypnea and hypertension, while CBC and CMP reveal leukocytosis and elevated creatinine and D-dimer levels.Chest CT results indicated a pericardial effusion along the apex of the heart.After admission, the patient's pacemaker leads were repositioned in the catheter lab, and he was prescribed colchicine prior to discharge.Based on the patient's clinical presentation and medical history, the patient's primary differential diagnosis is…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.